Orlistat augments postprandial increases in glucagon-like peptide 1 in obese type 2 diabetic patients. [electronic resource]
Producer: 20041116Description: 1077-80 p. digitalISSN:- 0149-5992
- Adult
- Aged
- Anti-Obesity Agents -- therapeutic use
- Cross-Over Studies
- Diabetes Mellitus -- blood
- Diabetes Mellitus, Type 2 -- blood
- Female
- Gastric Inhibitory Polypeptide -- blood
- Glucagon -- blood
- Glucagon-Like Peptide 1
- Humans
- Insulin -- blood
- Lactones -- therapeutic use
- Male
- Middle Aged
- Obesity
- Orlistat
- Peptide Fragments -- blood
- Protein Precursors -- blood
- Single-Blind Method
- Weight Loss
No physical items for this record
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.